Cost and Efficacy: an Update Stephen Curtin M.D. Bone marrow - - PowerPoint PPT Presentation

cost and efficacy an update stephen curtin m d bone marrow
SMART_READER_LITE
LIVE PREVIEW

Cost and Efficacy: an Update Stephen Curtin M.D. Bone marrow - - PowerPoint PPT Presentation

Cost and Efficacy: an Update Stephen Curtin M.D. Bone marrow Simple aspirate added to various synthetic bone Platelets Platelet Gel Platelet Rich Plasma Mesenchymal Stem Cells Osteoprogenitor Cells Cost


slide-1
SLIDE 1

Cost and Efficacy: an Update Stephen Curtin M.D.

slide-2
SLIDE 2
  • Bone marrow
  • Simple aspirate added to various “synthetic bone”
  • Platelets
  • Platelet Gel
  • Platelet Rich Plasma
  • Mesenchymal Stem Cells
  • Osteoprogenitor Cells
slide-3
SLIDE 3
  • Cost is in the Needle
  • Simple can be

aspirated from crest

  • r pedicle
  • Typically added to

allomatrix and DBM as an Extender

  • Ineffective as a Stand

alone in combination with collagen- hydroxyapatite sponge

slide-4
SLIDE 4
  • NovaBone : Calcium Phosphosilicate
  • Vitoss: “Porous” Calcium Phosphate and

Bioactive glass

  • ProOsteon: HA CaCO2 &CaPO4
  • Norian: CaPO4
  • MasterGraft: HA & B-TCP
slide-5
SLIDE 5
  • Autologous Growth

Factors

  • PDGF, TGF-B
  • Platelet Gel
  • Platelet Rich Plasma
  • Literature is mixed
  • Not recommended nor

supported at this time in spine surgery

  • Bone substitutes and

expanders in Spine Surgery: A review of their fusion efficacies Int J Spine Surg. 2016; 10: 33.

Abhijeet Kadam, MD,corresponding author1 Paul W Millhouse, MD,2 Christopher K Kepler, MD, MBA,2 Kris E. Radcliff, MD,2 Michael G. Fehlings, MD, PhD, FRCSC,3 Michael E. Janssen, DO,4 Rick C. Sasso, MD,5 James J. Benedict, PhD, MD,6 and Alexander R Vaccaro, MD, PhD, MBA2

  • Bone Graft and Bone Graft

Substitutes in Spine Surgery: Current Concepts and Controversies

JAAOS - Journal of the American Academy of Orthopaedic Surgeons: January 2013 - Volume 21 - Issue 1 – p51- 60 Grabowski, Gregory MD; Cornett, Chris A. MD

slide-6
SLIDE 6
  • Requires

Preparation/Centrifuge

  • Generally not covered

by insurance

  • No controlled clinical

trials

  • $5000 Back Pain

treatment

slide-7
SLIDE 7
  • Currently commercial

products are allograft

  • Limited Data
  • More Evidence is

Needed

  • Autogenous Banking

in the Future?

slide-8
SLIDE 8
  • Marrow Aspirate: theoretical advantage as an

adjunct, not stand alone, low cost

  • Platelets and PRP: No data or contradictory

data, high cost

  • Mesenchymal Progenitor Cells: Auto sources

are futuristic, costly, current Allo souces lack data